Microglia, the resident macrophages in the central nervous system (CNS), play a pivotal role in innate and adaptive immune responses in the brain. The immune functions of microglia are regulated by cytokines, including interferon (IFN)-g, which is a major mediator of macrophage activation. We describe the transcriptional profile of human fetal microglial cells at 1, 6, and 24 h after IFN-g treatment. The results show a change in the expression of 405 genes including transcriptionally induced chemokines, IFN-g signaling factors, and major histocompatibility complex genes. Our results demonstrate that activation of microglia by IFN-g induces proinflammatory T-lymphocyte-related chemokine genes as well as genes involved in antigen presentation. As a result, signals for T-cell infiltration and antigen presentation are produced to allow for microglia-T-cell interactions that likely contribute to defense against invading pathogens. In sum, our results provide a foundation for the molecular mechanisms of the microglial response to IFN-g-a key to understanding cell-mediated immunity of the CNS.
Introduction
The brain, like other organs of the body, must have a means to defend and protect itself from pathogens and other potentially dangerous entities present in the environment. However, the mechanisms of brain defense are of particular interest due to its 'immunologically privileged' status, conferred, in part, by the blood-brain barrier. A fine line exists, however, between proinflammatory responses to infection and detrimental effects of inflammation as witnessed by several neuroinflammatory and neurodegenerative disorders like multiple sclerosis. 1, 2 Although the blood-brain barrier is capable of blocking the ingress of cells of the systemic immune system, the brain is now recognized as having an intrinsic immune system, that is, astroglia and microglia. Of these glial cell populations, microglia (the resident macrophages of the brain) play a pivotal role in both innate and adaptive immune responses within the brain. Upon activation, microglia assume an amoeboid morphology and migrate toward sites of brain injury, including foci of infection and inflammation. 3 Their role in defense ranges from phagocytosis and killing of invading pathogens to production and release of a variety of cytokines, chemokines, and other mediators that contribute to the breakdown of the blood-brain barrier, leukocyte emigration into the nervous system, and tissue destruction. [4] [5] [6] [7] Interferon (IFN)-g is the principal macrophage-activating cytokine produced by NK cells, CD4 þ TH1 cells and CD8 þ T cells that serves critical functions in both innate and adaptive immunity. 8 IFN-g has been demonstrated to be a critical cytokine in the successful defense against a variety of viruses and many other intracellular pathogens, such as Mycobacterium tuberculosis and Toxoplasma gondii. [8] [9] [10] [11] Not surprisingly, IFN-g also appears to be a key cytokine in the induction of an activated state of microglial cells. 12, 13 In murine models, microglia show significantly increased myelin phagocytosis, proteolytic enzyme secretion, and oxidative burst activity in response to IFN-g as compared with tissue macrophages, suggesting that microglial cells may be functionally distinct from macrophages present in other sites. 14 Despite recognition of the pivotal role of microglia in defense of the central nervous system (CNS) and in neuropathogenesis, and the well-recognized importance of IFN-g as a key activating cytokine, surprisingly little is known about the molecular influence of IFN-g on gene expression in human microglial cells. 15, 16 The objective of this study was to determine the transcriptional profile of human microglial cells exposed to IFN-g using microarray analysis. The results provide a comprehensive view of the transcriptional response of human microglial cells to stimulation with IFN-g and provide insight regarding major pathways associated with the activated state and those involved in signal transduction and immune effector functions.
Results and discussion

Data summary
To characterize the effects of IFN-g gene expression in microglia, microglial cells were either untreated (control) or treated with 200 U/ml of a recombinant human form of IFN-g. Following treatment with IFN-g, microglial cells were lysed and homogenized at 1, 6, and 24 h postexposure for RNA extraction and probe synthesis that was applied to Affymetrix Human Genome U133A chips, which contain 33 000 genes. Microglia maintained their viability upon exposure to IFN-g as measured by MTT assay (data not shown). The supernatants from IFN-g-treated and -untreated cells were also collected for ELISA analysis at 1, 6, and 24 h post-treatment. The complete experiment was repeated a total of four times using microglial cells isolated from four different brain specimens. The data discussed in this publication have been deposited in NCBIs Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and are accessible through GEO Series accession number GSE1432.
For sample processing, Affymetrix human genome slides and standardized techniques were used. Statistical algorithms (based on Tukey's biweight methods) provided by Affymetrix that determine initial spot intensities to report a signal log ratio by comparing the control vs the experimental group with 95% confidence intervals were used for data processing. 17, 18 Overall, this approach is reproducible and statistically robust, revealing genes that are present or absent, and their relative expression levels. With this method, 59.14% genes were expressed in at least one time point. Instead of focusing on all of these genes identified in the analysis, we chose to focus on a smaller, more manageable fraction of the genes that exhibited the greatest change in expression in at least two time points. In addition, in order to help our efforts on identifying those genes that had a relatively large level of alteration in gene expression, we chose to use a two-fold cutoff as a significant change in expression. Our rationalization of the two-fold cutoff was based on the fact that a 1.5-to 2.0-fold cutoff appears to ensure reproducibility and accuracy of microarray-based data and has been used by several other research groups in recent studies. [18] [19] [20] [21] Hence, we identified a total of 329 genes that were increased in expression and a total of 76 genes were decreased in expression in response to IFN-g. Not surprisingly, prominent among the genes found to be stimulated were those related to immune function, including immune effectors such as chemokine and major histocompatibility complex (MHC) genes along with those identified in Table 1 . With a more detailed analysis of the genes altered in expression, we were able to provide a better foundation for understanding the molecular response of human microglia to one of the principal proinflammatory cytokines, IFN-g.
Chemokine genes stimulated by IFN-c Owing to the important role chemokines play in immune cell trafficking and migration, we chose to examine specifically the expression patterns of all the chemokines present on the Affymetrix Human Genome U133A chip when microglia were exposed to IFN-g. 22 Most notable among genes increased in expression were those involved in mixed leukocyte and T-lymphocyte recruitment. Importantly, and in support of previous research, these data suggest that IFN-g not only plays a role in stimulating human microglia to recruit T cells but also other immune-related cells into the CNS.
Of notable interest was the marked stimulation of CXCL10/IP-10, CXCL11/I-TAC and CXCL9/MIG by IFN-g at both the transcript and protein level (Table 1, Figure 1 ). These chemokines are all important mediators of T-cell recruitment. These results are consistent with previous studies that found a similar response in human monocytes exposed to IFN-g as well as data showing an induction of CXCL10/IP-10 in human fetal microglia exposed to IFN-g. 23, 24 Of particular interest here was the magnitude of the increase in transcription observed for this class of genes. As a group, they were among the genes that had the highest magnitude of change discovered in this analysis. For instance, CXCL11/ I-TAC gene expression showed a 1647-fold increase as compared with untreated microglial cells at 24 h. These findings were confirmed using both quantitative RT-PCR as well as ELISA, with a 126-fold increase observed for the CXCL11/I-TAC protein ( Figure 1 ). This may represent an exquisite sensitivity that human microglial cells possess in response to IFN-g, especially when it relates to T-lymphocyte recruitment.
Another attractant of memory T-lymphocytes as well as monocytes, CCL5/RANTES, showed a six-fold increase in expression at the 6 and 24 h time points. 25 This response was verified at both the mRNA and protein levels with quantitative RT-PCR and ELISA assays ( Figure 1 ). Human microglia synthesize CCL5/RANTES in response to proinflammatory stimuli, such as IL-1b and TNF-a, and the anti-inflammatory cytokines IL-10 and TGF-b downregulate its production. 26 Previous studies on human fetal microglia and monocyte-derived macrophages, however, have not demonstrated an increased CCL5/RANTES production in response to IFN-g. 15, 16 While the reasons for this discrepancy are not clear, the results show an increased expression of CCL5/ RANTES at both the mRNA and protein level, confirming that there is a significant increase in the expression of this mediator in response to IFN-g stimulation in microglial cells.
Not only did IFN-g induce an increased expression of CCL5/RANTES, a chemokine involved in T-cell and monocyte recruitment, but other chemokines involved in mixed lymphocyte recruitment were stimulated as well. In particular, the genes encoding CCL2/MCP-1, CCL8/ MCP-2, CCL7/MCP-3, and CCL4/MIP-1b were all increased in expression in response to IFN-g (Table 1 ). For example, CCL2/MCP-1 showed an initial 20-fold increase in gene expression at 1 h and a less robust increase, three-and eight-fold at 6 and 24 h, respectively. ELISA and RT-PCR assays for CCL2/MCP-1 confirmed these results and demonstrated a steady rise in mRNA and protein production ( Figure 1 ). This is noteworthy since CCL2/MCP-1 is known to be a chemoattractant for monocytes, activated T cells, and basophils. 27 These results are also consistent with previous studies that have shown increased expression of CCL2 by IFN-g in human peritoneal macrophages, human monocytes, and human microglia. 16, 23, 28 In addition, CCL4/ MIP-1b, a stimulus for monocyte, NK cell and CD4 þ T-lymphocyte recruitment, showed a modest two-to four-fold increase in gene expression (Table 1) . 29 Previous investigations of human fetal microglia, however, found no significant production of the CCL4/MIP-1b mRNA or protein by IFN-g activation. 15, 16, 24 This contradictory finding may simply reflect the greater sensitivity of microarray analysis for assessing gene expression than other techniques, or that the enhanced gene expression does not result in a corresponding increase in protein expression. RT-PCR confirmed.
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Further supporting the role of microglia stimulation of mixed lymphocyte recruitment in response to IFN-g, our results show that CXCR4 was substantially suppressed by IFN-g (Table 1 , Figure 1 ). CXCR4 is a chemokine receptor and was the only receptor to have a significant transcriptional response to IFN-g (data not shown). CXCR4 is the specific receptor for CXCL12/SDF-1 that is involved in mixed leukocyte recruitment. CXCL12/ SDF-1 gene expression was not significantly affected (Table 1) . A recent study of the adult human microglial cell line CHME3 found no significant modulation of chemokine receptor expression after exposure to IFN-g, including CXCR4, although in the murine system, CXCR4 has been shown to be suppressed by IFN-g. 30, 31 The suppression of the CXCR4 gene in human fetal microglial cells as found in the current investigation may represent a unique response of fetal microglia as compared with adult microglia. Further studies will be required to investigate this hypothesis.
Some CXC chemokines were not significantly stimulated. Most notably, CXCL8/IL-8 and CXCL5/ENA-78, which are thought to primarily function in neutrophil recruitment, were not significantly stimulated by IFNg. 32, 33 This observation is especially noteworthy since human fetal microglial cells have been shown to produce CXCL8/IL-8 when stimulated with LPS, IL-1b, and TNFa, and CXCL8/IL-8 was downregulated in response to IL-4, IL-10, and TGF-b1. 34 In our study, the gene encoding CXCL8/IL-8 showed a three-fold increase at the 24 h time point, but not at any of the other times examined (Table 1) , and hence the significance of this apparent transient increase is unclear.
In sum, our results suggest that IFN-g stimulates microglial cells to produce a variety of chemokines, which are involved in T-cell recruitment as well as in the recruitment of monocytes, basophils, and natural killer cells. Of particular interest is the high magnitude of expression of those genes involved in T-cell recruitment. This may suggest a preferential recruitment for T cells, which needs to be further elucidated. with IFN-g, microglia increased the expression of genes for several members of the MHC genes (Table 1) . For instance, MHC Class I genes including polypeptide sequence A (MICA) and mRNA fragment 3.8-1 were increased in expression 25-and four-fold, respectively. The results show that MHC Class II genes were also increased in expression, including MHC Class II transactivator (MHC2TA), HLA DQB1, HLA DRA, and HLA DPA1. This was not unexpected since the stimulation of MHC Class II gene expression by IFN-g has previously been described in several cell types, including rat microglial cells. 35 An increase in the expression of the MHC Class I and II genes suggests an activation of microglial cell antigen-processing and presentation functions in response to IFN-g stimulation.
IFN-c alters expression of signal transduction genes
The consequences of IFN-g stimulation are primarily initiated through the activation of its receptor through associated Janus tyrosine kinases (JAK) on the surface of Figure 2 Schematic diagram showing a general overview of selected elements of the IFN-g-induced gene response of human microglial cells identified in this study. Biological elements are depicted as increased (black), decreased (white), or unchanged (stripe) gene expression. Solid arrows from the cell nucleus designate gene expression that was confirmed with RT-PCR and/or ELISA data, whereas dashed arrows designate only gene expression results. Primary human microglial cell cultures were prepared as described previously. 34 Human brain tissues were obtained under a protocol approved by the Human Subjects Research Committee at our institution. Briefly, brain tissue from 16-to 20-week-old fetuses was obtained at the time of elective termination of intrauterine pregnancy from otherwise normal healthy individuals. Cells were dissociated by trypsinization (0.25%) for 30 min and plated into 75-cm 2 Falcon tissue culture flasks in Dulbecco's modified Eagle's medium (DMEM) (Sigma Chemical Co., St Louis, MO, USA) containing 10% heat-inactivated fetal bovine serum (FBS) (Hyclone Laboratories, Logan, UT, USA), penicillin (100 U/ml), and streptomycin (100 mg/ml) (Sigma). Cells were incubated for 10-14 days with weekly medium changes. Microglial cells floating in the medium of mixed cultures were collected, centrifuged, and reseeded in uncoated six-well tissue culture plates (2.5 Â 10 6 cells/well) with fresh medium. The cultures were washed 1 h after seeding to remove nonadherent cells. Purified microglia were composed of a cell population of which 499% stained with anti-CD68 antibody (a human macrophage marker) and o1% stained with anti-GFAP antibody (an astrocyte marker) (Dako, Carpinteria, CA, USA). 4 The microglial cells then were either untreated or treated with 200 U/ml of the human recombinant form of IFN-g (R&D Systems, Minneapolis, MN, USA). 42, 45, 49, 50 Results in our lab have shown that human microglia respond in a dose-dependent manner after exposure to IFN-g at concentrations ranging from 0.2 to 200 U/ml (data not shown). Following microglial cell lysis and homogenization, total RNA was extracted from microglial cells using the Qiagen RNeasy mini kit as per the manufacturer's instructions (Qiagen Inc., Valencia, CA, USA). The total RNA sample plus a T7-Oligo(dt) promoter primer (Affymetrix, Santa Clara, CA, USA) was incubated at 701C for 10 min. dNTPs and DTT were added and incubated at 421C for 2 min. SSII Reverse Transcriptase was added and incubated at 421C for 60 min. Single-stranded cDNA plus dNTPs, DNA ligase, DNA polymerase (Escherichia coli derived), and RNase H were mixed and incubated at 161C for 2 h. T4 DNA polymerase was added and incubated at 161C for 5 min. Phase-lock gels were used for phenol/chloroform extraction and ethanol precipitation to remove residual RNA. Biotin labeling was performed using the Enzo BioArray High Yield RNA Transcript Labeling Kit (Enzo Diagnostics, Farmingdale, NY, USA). Double-stranded cDNA plus biotin-labeled ribonucleotides, DTT, RNase inhibitor mix, and T7 RNA polymerase were mixed and incubated at 371C for 5 h. Ethanol and 2-mercaptoethanol were used to clean up the final product. Fragmentation was performed using 5 Â fragmentation buffer. Hybridizations was completed with 15 mg of the fragmented biotin-labeled cRNA as per standard Affymetrix protocol (Santa Clara, CA, USA) and scanned with a Genearray Scanner (Agilent Technologies, Palo Alto, CA, USA). many immune cells. Upon IFN-g binding, these kinases phosphorylate both the IFN-g receptor and the signal transducer and activator of transcription (STAT)-1. Phosphorylated STAT-1 homodimerizes, translocates to the nucleus, and activates gamma-activated sequence elements of IFN-g-responsive genes. 36 Thus, we examined the expression of the genes involved in these activation pathways in IFN-g-stimulated microglia.
As expected, the results of our analysis show an increase in transcription of IFN-g-related signal transduction pathway genes upon stimulation with IFN-g (Figure 1 ). For instance, Janus kinase 2 (JAK2) and STAT-1 were both significantly increased in expression by eight-and five-fold, respectively (Table 1 ). In contrast, the gene encoding IFN-g receptor 1 decreased by more than three-fold and IFN-g receptor 2 was unchanged in expression during IFN stimulation.
Taken together, the results support the hypothesis that while there is specific activation of this signal transduction pathway during IFN-g stimulation, this effect is likely moderated through a feedback mechanism that includes, for instance, the suppression of IFN-g receptor elements and increased expression of STAT-induced inhibitor 1 (SSI-1) (Table 1) . Since, SSI-1 functions primarily as an inhibitor of cytokine production by binding to JAK1, JAK2, JAK3, and TYK2, thereby inhibiting the phosphorylation of STAT and the production of cytokines such as IL-2, IL-3, EPO, and GH, it's rapid and dramatic induction by IFN-g in human microglial cells likely represents a regulatory mechanism whose role in the immune stimulation of microglial cells requires further investigation. 37 Toll-like receptor (TLR) gene expression is not appreciably altered during stimulation with IFN-c TLR genes 2, 3, 4, and 6 are important pattern recognition receptors for a number of microbial pathogens. Consistent with this, previous studies have shown that TLR2 and TLR4 are increased in expression upon IFN-g stimulation of human monocyte-derived macrophages and human endothelial cells. 38, 39 Studies from our laboratories and elsewhere have shown that human microglia express a broad range of TLRs, and that these are regulated both in vivo and in vitro, with increased expression associated with inflammation in the CNS. 40 Surprisingly, the results of our investigations show that TLR2, 3, 4, and 6 were not affected upon IFN-g stimulation (data not shown). In addition, the gene encoding TLR5, a molecule that is associated with the recognition of bacterial flagellin, showed decreased expression at the later (6 and 24 h) time points (Table 1) .
Nitric oxide synthase-2 (NOS2) was not upregulated by IFN-c IFN-g-inducible NOS2 has been shown to be a primary effector mechanism of macrophages for the killing of M. tuberculosis, T. gondii, and other infectious agents in murine models of infection. 31, 41 However, controversy surrounds the importance of this antimicrobial mechanism in human macrophages and microglial cells. [42] [43] [44] Our results showed no increase in expression of NOS gene(s) in response to IFN-g, which is in contrast to results found in the murine model, but correlates with previous examination of human microglial cells in our laboratory. 45 This difference suggests a possible species-specific response to IFN-g, which may have implications as to the specific mechanism of effective killing that is employed against intracellular organisms such as M. tuberculosis. 46, 47 Why this antimicrobial mechanism may be less important in the human CNS than in the murine CNS is unknown, but it has been hypothesized that a benefit may be conferred by reduced nitric oxide (NO) associated neuronal toxicity. 45, 48 Implications for microbial infections of the CNS The effect of IFN-g on human microglial cell gene expression demonstrated in this study revealed major groups of genes that are transcriptionally induced, including a number of chemokines, IFN-g signaling factors, and MHC I and II genes. The strong stimulation of proinflammatory T-lymphocyte-specific chemokine genes as well as MHC genes involved in antigen presentation, identifies the expression of essential components required for efficient T-cell infiltration and antigen presentation necessary for microglia-T-cell interaction to generate an adaptive immune response. These findings point to the important role that microglia play in attracting T-lymphocytes into the CNS, which is critical to the defense against a myriad of intracellular pathogens.
Concluding comments
The results of our investigations have enabled us to develop a 'synthesis model' of what happens when human microglial cells are stimulated with IFN-g and reveal the particularities and commonalities of human microglia to their counterparts in other tissues (Figure 2 ). In summary, our investigation demonstrates the utility of assessing inflammatory genomic responses of human microglia to IFN-g by microarray analysis and considerably expands the current knowledge on the response of human microglial cells to IFN-g, widely recognized as a key to understanding cell-mediated immunity of the CNS.
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